Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.1030
+0.0005 (0.49%)
At close: Dec 5, 2025
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 126.44 million as of December 5, 2025. Its market cap has decreased by -35.83% in one year.
Market Cap
126.44M
Enterprise Value
144.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 126.44M, a decrease of -83.52%. That is a compound annual growth rate of -48.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 126.44M | -45.79% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.36T |
| Coloplast | 131.88B |
| Genmab | 127.02B |
| ALK-Abelló | 50.74B |
| Demant | 45.41B |
| H. Lundbeck | 42.14B |
| Zealand Pharma | 35.55B |
| Ambu A/S | 23.18B |